P22682
Gene name |
Cbl |
Protein name |
E3 ubiquitin-protein ligase CBL |
Names |
EC 2.3.2.27 , Casitas B-lineage lymphoma proto-oncogene , Proto-oncogene c-Cbl , RING-type E3 ubiquitin transferase CBL , Signal transduction protein CBL |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:12402 |
EC number |
2.3.2.27: Aminoacyltransferases |
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
45-351 (TKBD) |
Relief mechanism |
PTM |
Assay |
|
Target domain |
47-349 (TKB domain) |
Relief mechanism |
PTM |
Assay |
|
Accessory elements
No accessory elements
References
- Dou H et al. (2012) "Structural basis for autoinhibition and phosphorylation-dependent activation of c-Cbl", Nature structural & molecular biology, 19, 184-92
- Wybenga-Groot LE et al. (2021) "SLAP2 Adaptor Binding Disrupts c-CBL Autoinhibition to Activate Ubiquitin Ligase Function", Journal of molecular biology, 433, 166880
- Kobashigawa Y et al. (2011) "Autoinhibition and phosphorylation-induced activation mechanisms of human cancer and autoimmune disease-related E3 protein Cbl-b", Proceedings of the National Academy of Sciences of the United States of America, 108, 20579-84
Autoinhibited structure

Activated structure

2 structures for P22682
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
2D9S | NMR | - | A/B | 863-902 | PDB |
AF-P22682-F1 | Predicted | AlphaFoldDB |
48 variants for P22682
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
rs3389007313 | 241 | I>N | No | EVA | |
rs3389032619 | 262 | T>S | No | EVA | |
rs3389041995 | 265 | G>V | No | EVA | |
rs3399749028 | 287 | G>A | No | EVA | |
rs3389036619 | 300 | Q>E | No | EVA | |
rs3388986057 | 301 | W>* | No | EVA | |
rs3389037274 | 325 | A>P | No | EVA | |
364 | E>del | oncogenic variant 70Z/3 [UniProt] | No | ||
rs3389040366 | 428 | V>M | No | EVA | |
rs3389012941 | 489 | A>D | No | EVA | |
rs3389027381 | 489 | A>T | No | EVA | |
rs3547295013 | 509 | A>S | No | EVA | |
rs3389027401 | 528 | D>V | No | EVA | |
rs3547258979 | 534 | P>S | No | EVA | |
rs3547216374 | 552 | V>A | No | EVA | |
rs3547383153 | 558 | P>L | No | EVA | |
rs3547259696 | 561 | R>C | No | EVA | |
rs3547241581 | 583 | R>C | No | EVA | |
rs3547201409 | 590 | S>F | No | EVA | |
rs3389046290 | 597 | P>L | No | EVA | |
rs3547219710 | 601 | P>L | No | EVA | |
rs3547201492 | 606 | P>L | No | EVA | |
rs3547259191 | 611 | E>G | No | EVA | |
rs224974500 | 615 | R>Q | No | EVA | |
rs3547259736 | 618 | L>F | No | EVA | |
rs3547246776 | 624 | S>T | No | EVA | |
rs3547259491 | 632 | V>F | No | EVA | |
rs3388986031 | 643 | T>N | No | EVA | |
rs3389032024 | 644 | S>F | No | EVA | |
rs236909014 | 646 | T>N | No | EVA | |
rs3400169368 | 671 | I>L | No | EVA | |
rs3400077706 | 671 | I>M | No | EVA | |
rs3399533273 | 673 | S>N | No | EVA | |
rs3547330979 | 743 | I>M | No | EVA | |
rs3547330987 | 746 | Q>K | No | EVA | |
rs3547383020 | 827 | R>W | No | EVA | |
rs3547203497 | 834 | R>P | No | EVA | |
rs3547259202 | 849 | G>R | No | EVA | |
rs3547198141 | 853 | A>V | No | EVA | |
rs3389032015 | 855 | P>H | No | EVA | |
rs3547216117 | 860 | P>L | No | EVA | |
rs3389038970 | 865 | S>L | No | EVA | |
rs1134142566 | 867 | E>* | No | EVA | |
rs3547259198 | 873 | S>T | No | EVA | |
rs1135315060 | 880 | D>N | No | EVA | |
rs1132936140 | 887 | I>N | No | EVA | |
rs1132341532 | 895 | A>T | No | EVA | |
rs3547203715 | 900 | R>W | No | EVA |
1 associated diseases with P22682
Without disease ID
8 regional properties for P22682
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | Zinc finger, RING-type | 379 - 418 | IPR001841 |
domain | Adaptor protein Cbl, N-terminal helical | 49 - 173 | IPR003153 |
domain | Adaptor protein Cbl, EF hand-like | 177 - 260 | IPR014741 |
domain | Adaptor protein Cbl, SH2-like domain | 254 - 350 | IPR014742 |
domain | Ubiquitin-associated domain | 863 - 902 | IPR015940 |
conserved_site | Zinc finger, RING-type, conserved site | 394 - 403 | IPR017907 |
domain | Zinc finger, C3HC4 RING-type | 379 - 417 | IPR018957 |
domain | Adaptor protein Cbl, PTB domain | 45 - 349 | IPR024159 |
Functions
Description | ||
---|---|---|
EC Number | 2.3.2.27 | Aminoacyltransferases |
Subcellular Localization |
|
|
PANTHER Family | ||
PANTHER Subfamily | ||
PANTHER Protein Class | ||
PANTHER Pathway Category | No pathway information available |
10 GO annotations of cellular component
Name | Definition |
---|---|
axon | The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter. |
cilium | A specialized eukaryotic organelle that consists of a filiform extrusion of the cell surface and of some cytoplasmic parts. Each cilium is largely bounded by an extrusion of the cytoplasmic (plasma) membrane, and contains a regular longitudinal array of microtubules, anchored to a basal body. |
cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
flotillin complex | A protein complex that contains flotillin-1 and flotillin-2, and may contain associated proteins. Flotillins associate into membrane microdomains resembling caveolae. |
focal adhesion | A cell-substrate junction that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments. In insects focal adhesion has also been referred to as hemi-adherens junction (HAJ). |
Golgi apparatus | A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways. |
growth cone | The migrating motile tip of a growing neuron projection, where actin accumulates, and the actin cytoskeleton is the most dynamic. |
membrane raft | Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions. |
perinuclear region of cytoplasm | Cytoplasm situated near, or occurring around, the nucleus. |
plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
9 GO annotations of molecular function
Name | Definition |
---|---|
calcium ion binding | Binding to a calcium ion (Ca2+). |
ephrin receptor binding | Binding to an ephrin receptor. |
phosphatidylinositol 3-kinase regulatory subunit binding | Binding to a regulatory subunit of phosphatidylinositol 3-kinase. The regulatory subunit associates with the catalytic subunit to regulate both its activity and subcellular location. |
phosphotyrosine residue binding | Binding to a phosphorylated tyrosine residue within a protein. |
protein kinase binding | Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate. |
protein tyrosine kinase binding | Binding to protein tyrosine kinase. |
receptor tyrosine kinase binding | Binding to a receptor that possesses protein tyrosine kinase activity. |
SH3 domain binding | Binding to a SH3 domain (Src homology 3) of a protein, small protein modules containing approximately 50 amino acid residues found in a great variety of intracellular or membrane-associated proteins. |
ubiquitin protein ligase activity | Catalysis of the transfer of ubiquitin to a substrate protein via the reaction X-ubiquitin + S -> X + S-ubiquitin, where X is either an E2 or E3 enzyme, the X-ubiquitin linkage is a thioester bond, and the S-ubiquitin linkage is an amide bond |
27 GO annotations of biological process
Name | Definition |
---|---|
bone resorption | The process in which specialized cells known as osteoclasts degrade the organic and inorganic portions of bone, and endocytose and transport the degradation products. |
cell surface receptor signaling pathway | The series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription. |
cellular response to hypoxia | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. |
cellular response to nerve growth factor stimulus | A process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nerve growth factor stimulus. |
cellular response to platelet-derived growth factor stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a platelet-derived growth factor stimulus. |
DNA damage response | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to its DNA from environmental insults or errors during metabolism. |
male gonad development | The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure. |
mast cell degranulation | The regulated exocytosis of secretory granules containing preformed mediators such as histamine, serotonin, and neutral proteases by a mast cell. |
negative regulation of apoptotic process | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
negative regulation of epidermal growth factor receptor signaling pathway | Any process that stops, prevents, or reduces the frequency, rate or extent of epidermal growth factor receptor signaling pathway activity. |
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B. |
positive regulation of receptor-mediated endocytosis | Any process that activates or increases the frequency, rate or extent of receptor mediated endocytosis, the uptake of external materials by cells, utilizing receptors to ensure specificity of transport. |
protein autoubiquitination | The ubiquitination by a protein of one or more of its own amino acid residues, or residues on an identical protein. Ubiquitination occurs on the lysine residue by formation of an isopeptide crosslink. |
protein monoubiquitination | Addition of a single ubiquitin group to a protein. |
protein phosphorylation | The process of introducing a phosphate group on to a protein. |
protein polyubiquitination | Addition of multiple ubiquitin groups to a protein, forming a ubiquitin chain. |
protein ubiquitination | The process in which one or more ubiquitin groups are added to a protein. |
regulation of platelet-derived growth factor receptor-alpha signaling pathway | Any process that modulates the frequency, rate or extent of platelet-derived growth factor receptor-alpha signaling pathway. |
regulation of Rap protein signal transduction | Any process that modulates the frequency, rate or extent of Rap protein signal transduction. |
response to activity | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an activity stimulus. |
response to ethanol | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus. |
response to gamma radiation | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gamma radiation stimulus. Gamma radiation is a form of electromagnetic radiation (EMR) or light emission of a specific frequency produced from sub-atomic particle interaction, such as electron-positron annihilation and radioactive decay. Gamma rays are generally characterized as EMR having the highest frequency and energy, and also the shortest wavelength, within the electromagnetic radiation spectrum. |
response to starvation | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a starvation stimulus, deprivation of nourishment. |
response to testosterone | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a testosterone stimulus. |
signal transduction | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
ubiquitin-dependent endocytosis | Endocytosis of a protein that requires the substrate to be modified by ubiquitination. Several plasma membrane proteins, including cell surface permeases and some receptors, are targeted for internalization by endocytosis, and are thereafter delivered to the vacuole or lysosome, where they are degraded. |
ubiquitin-dependent protein catabolic process | The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of a ubiquitin group, or multiple ubiquitin groups, to the protein. |
7 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | Homo sapiens (Human) | EV |
Q9ULV8 | CBLC | E3 ubiquitin-protein ligase CBL-C | Homo sapiens (Human) | SS |
P22681 | CBL | E3 ubiquitin-protein ligase CBL | Homo sapiens (Human) | EV |
Q3TTA7 | Cblb | E3 ubiquitin-protein ligase CBL-B | Mus musculus (Mouse) | SS |
Q80XL1 | Cblc | E3 ubiquitin-protein ligase CBL-C | Mus musculus (Mouse) | SS |
Q8K4S7 | Cblb | E3 ubiquitin-protein ligase CBL-B | Rattus norvegicus (Rat) | SS |
G3V8H4 | Cblc | E3 ubiquitin-protein ligase CBL-C | Rattus norvegicus (Rat) | SS |
10 | 20 | 30 | 40 | 50 | 60 |
MAGNVKKSSG | AGGGGSGGSG | AGGLIGLMKD | AFQPHHHHHH | LSPHPPCTVD | KKMVEKCWKL |
70 | 80 | 90 | 100 | 110 | 120 |
MDKVVRLCQN | PKLALKNSPP | YILDLLPDTY | QHLRTVLSRY | EGKMETLGEN | EYFRVFMENL |
130 | 140 | 150 | 160 | 170 | 180 |
MKKTKQTISL | FKEGKERMYE | ENSQPRRNLT | KLSLIFSHML | AELKGIFPSG | LFQGDTFRIT |
190 | 200 | 210 | 220 | 230 | 240 |
KADAAEFWRK | AFGEKTIVPW | KSFRQALHEV | HPISSGLEAM | ALKSTIDLTC | NDYISVFEFD |
250 | 260 | 270 | 280 | 290 | 300 |
IFTRLFQPWS | SLLRNWNSLA | VTHPGYMAFL | TYDEVKARLQ | KFIHKPGSYI | FRLSCTRLGQ |
310 | 320 | 330 | 340 | 350 | 360 |
WAIGYVTADG | NILQTIPHNK | PLFQALIDGF | REGFYLFPDG | RNQNPDLTGL | CEPTPQDHIK |
370 | 380 | 390 | 400 | 410 | 420 |
VTQEQYELYC | EMGSTFQLCK | ICAENDKDVK | IEPCGHLMCT | SCLTSWQESE | GQGCPFCRCE |
430 | 440 | 450 | 460 | 470 | 480 |
IKGTEPIVVD | PFDPRGSGSL | LRQGAEGAPS | PNYDDDDDER | ADDSLFMMKE | LAGAKVERPS |
490 | 500 | 510 | 520 | 530 | 540 |
SPFSMAPQAS | LPPVPPRLDL | LQQRAPVPAS | TSVLGTASKA | ASGSLHKDKP | LPIPPTLRDL |
550 | 560 | 570 | 580 | 590 | 600 |
PPPPPPDRPY | SVGAETRPQR | RPLPCTPGDC | PSRDKLPPVP | SSRPGDSWLS | RPIPKVPVAT |
610 | 620 | 630 | 640 | 650 | 660 |
PNPGDPWNGR | ELTNRHSLPF | SLPSQMEPRA | DVPRLGSTFS | LDTSMTMNSS | PVAGPESEHP |
670 | 680 | 690 | 700 | 710 | 720 |
KIKPSSSANA | IYSLAARPLP | MPKLPPGEQG | ESEEDTEYMT | PTSRPVGVQK | PEPKRPLEAT |
730 | 740 | 750 | 760 | 770 | 780 |
QSSRACDCDQ | QIDSCTYEAM | YNIQSQALSV | AENSASGEGN | LATAHTSTGP | EESENEDDGY |
790 | 800 | 810 | 820 | 830 | 840 |
DVPKPPVPAV | LARRTLSDIS | NASSSFGWLS | LDGDPTNFNE | GSQVPERPPK | PFPRRINSER |
850 | 860 | 870 | 880 | 890 | 900 |
KASSYQQGGG | ATANPVATAP | SPQLSSEIER | LMSQGYSYQD | IQKALVIAHN | NIEMAKNILR |
910 | |||||
EFVSISSPAH | VAT |